Form 4: Rocket Pharmaceuticals' General Counsel, Martin Wilson, Reports Stock Transactions
SEC Form 4 Filing
Martin Wilson, General Counsel of Rocket Pharmaceuticals, reports the acquisition and disposal of common stock and restricted stock units (RSUs).
Summary
- On May 14, 2024, Martin Wilson acquired 2,420 shares of common stock and disposed of 21,100 shares.
- These transactions are related to the vesting of Restricted Stock Units (RSUs).
- Wilson also reports previously unrecorded RSU grants from August 12, 2022, and February 14, 2023, now included in Table I.
- On May 16, 2024, Wilson sold 1,048 shares at $23.35 to cover tax obligations related to RSU vesting.
- Following these transactions, Wilson directly owns 65,762 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by an insider.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for corporate insiders in the US, ensuring transparency in stock transactions.
- Similar filings are common across publicly traded companies, such as those by executives at comparable biotech firms like Bluebird Bio or CRISPR Therapeutics.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
- The sale of shares to cover tax obligations is a common practice and may have a minor impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| 08/12/2022 | Initial grant date of RSUs now reported on Table I. |
| 02/14/2023 | Initial grant date of RSUs now reported on Table I. |
| 05/14/2024 | Acquisition of 2,420 shares and disposal of 21,100 shares related to RSU vesting. |
| 05/16/2024 | Sale of 1,048 shares at $23.35 to cover tax obligations. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.